Gw Pharmaceuticals reported $160.25M in Current Liabilities for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Aerie Pharmaceuticals AERI:US $ 118.13M 10.04M
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 452.98M 69.54M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Clovis Oncology CLVS:US $ 112.69M 61.19M
Flexion Therapeutics FLXN:US $ 43.99M 4.06M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Heron Therapeutics HRTX:US $ 72.3M 9.85M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Moderna Inc MRNA:US 9.96B 1.12B
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Prothena PRTA:US 29.2M 23.7M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Puma Biotechnology PBYI:US $ 116.26M 21.64M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
YTE INCY:US $ 742.71M 82.39M
Zogenix ZGNX:US $ 78.43M 9.09M